Mucosal inflammation in the terminal ileum of ulcerative colitis patients: Endoscopic findings and cytokine profiles

Digestive and Liver Disease

Volumn 40, Issue 4, 2008, Pages 253-259

  Yamamoto, Takayuki ^a   Maruyama, Yasuki ^a   Umegae, Satoru ^a   Matsumoto, Koichi ^a   Saniabadi, Abbi R ^b  

^a MIE UNIVERSITY   (Japan)

^b HAMAMATSU UNIVERSITY   (Japan)

Author keywords

Backwash ileitis; Cytokine; Extraintestinal manifestations; Immunological reactions; Mucosal inflammation; Terminal ileum; Ulcerative colitis

Indexed keywords

CORTICOSTEROID; CYTOKINE; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MESALAZINE; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGE; ARTICLE; CLINICAL FEATURE; COLON BIOPSY; COLONOSCOPY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN TISSUE; ILEITIS; ILEUM MUCOSA; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; SEX; STATISTICAL SIGNIFICANCE; ULCERATIVE COLITIS;

ADULT; COLITIS, ULCERATIVE; CYTOKINES; ENDOSCOPY, GASTROINTESTINAL; FEMALE; HUMANS; ILEUM; INTERLEUKIN-1BETA; INTERLEUKIN-6; INTERLEUKIN-8; INTESTINAL MUCOSA; MALE; PROSPECTIVE STUDIES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 39749156412     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2007.11.020     Document Type: Article

References (30)

1. Farmer R.G., Easley K.A., and Rankin G.B. Clinical patterns, natural history, and progression of ulcerative colitis. A long-term follow-up of 1116 patients. Dig Dis Sci 38 (1993) 1137-1146
2. Andres P.G., and Friedman L.S. Epidemiology and the natural course of inflammatory bowel disease. Gastroenterol Clin North Am 28 (1999) 255-281
3. Gustavsson S., Weiland L.H., and Kelly K.A. Relationship of backwash ileitis to ileal pouchitis after ileal pouch-anal anastomosis. Dis Colon Rectum 30 (1987) 25-28
4. Newman S.L. Ileoscopy, colonoscopy, and backwash ileitis in children with inflammatory bowel disease: quid pro quo?. J Pediatr Gastroenterol Nutr 6 (1987) 325-327
5. Perisic V.N., and Filipovic D. Ileoscopy and its clinical role in the assessment of backwash ileitis in children with ulcerative pancolitis: belgrade experience. J Pediatr Gastroenterol Nutr 7 (1988) 146-148
6. Heuschen U.A., Hinz U., Allemeyer E.H., Stern J., Lucas M., Autschbach F., et al. Backwash ileitis is strongly associated with colorectal carcinoma in ulcerative colitis. Gastroenterology 120 (2001) 841-847
7. Delaney C.P., Fazio V.W., Remzi F.H., Hammel J., Church J.M., Hull T.L., et al. Prospective, age-related analysis of surgical results, functional outcome, and quality of life after ileal pouch-anal anastomosis. Ann Surg 238 (2003) 221-228
8. Hurst R.D., and Michelassi F. Ileal-pouch anal restorative proctocolectomy for ulcerative colitis. Adv Surg 38 (2004) 311-336
9. Sandborn W.J. Pouchitis following ileal pouch-anal anastomosis: definition, pathogenesis, and treatment. Gastroenterology 107 (1994) 1856-1860
10. Luukkonen P., Jarvinen H., Tanskanen M., and Kahri A. Pouchitis-recurrence of the inflammatory bowel disease?. Gut 35 (1994) 243-246
11. Simchuk E.J., and Thirlby R.C. Risk factors and true incidence of pouchitis in patients after ileal pouch-anal anastomoses. World J Surg 24 (2000) 851-856
12. Yantiss R.K., Sapp H.L., Farraye F.A., El-Zammar O., O'Brien M.J., Fruin A.B., et al. Histologic predictors of pouchitis in patients with chronic ulcerative colitis. Am J Surg Pathol 28 (2004) 999-1006
13. van Hogezand R.A., and Verspaget H.W. Selective immunomodulation in patients with inflammatory bowel disease-future therapy or reality?. Neth J Med 48 (1996) 64-67
14. MacDermott R.P. Alterations of the mucosal immune system in inflammatory bowel disease. J Gastroenterol 31 (1996) 907-916
15. Rogler G., and Andus T. Cytokines in inflammatory bowel disease. World J Surg 22 (1998) 382-389
16. Yamamoto T., Umegae S., Kitagawa T., and Matsumoto K. Mucosal cytokine production during remission after resection for Crohn's disease and its relationship to future relapse. Aliment Pharmacol Ther 19 (2004) 671-678
17. Yamamoto T., Umegae S., Kitagawa T., and Matsumoto K. Systemic and local cytokine production in quiescent ulcerative colitis and its relationship to future relapse: a prospective, pilot study. Inflamm Bowel Dis 11 (2005) 589-596
18. Yamamoto T., Umegae S., Kitagawa T., and Matsumoto K. The impact of the fecal stream and stasis on immunologic reactions in ileal pouch after restorative proctocolectomy for ulcerative colitis: a prospective, pilot study. Am J Gastroenterol 100 (2005) 2248-2253
19. Schreiber S., Nikolaus S., Hampe J., Hamling J., Koop I., Groessner B., et al. Tumour necrosis factor α and interleukin 1β in relapse of Crohn's disease. Lancet 353 (1999) 459-461
20. Arnott I.D.R., Drummond H.E., and Ghosh S. Gut mucosal secretion of interleukin 1β and interleukin-8 predicts relapse in clinically inactive Crohn's disease. Dig Dis Sci 46 (2001) 402-409
21. Meresse B., Rutgeerts P., Malchow H., Dubucquoi S., Dessaint J.P., Cohard M., et al. Low ileal interleukin 10 concentrations are predictive of endoscopic recurrence in patients with Crohn's disease. Gut 50 (2002) 25-28
22. Gionchetti P., Campieri M., Belluzzi A., Bertinelli E., Ferretti M., Brignola C., et al. Mucosal concentrations of interleukin-1 beta, interleukin-6, interleukin-8, and tumour necrosis factor-alpha in pelvic ileal pouches. Dig Dis Sci 39 (1994) 1525-1531
23. Patel R.T., Bain I., Youngs D., and Keighley M.R. Cytokine production in pouchitis is similar to that in ulcerative colitis. Dis Colon Rectum 38 (1995) 831-837
24. Bulois P., Tremaine W.J., Maunoury V., Gambiez L., Hafraoui S., Leteurtre L., et al. Pouchitis is associated with mucosal imbalance between interleukin-8 and interleukin-10. Inflamm Bowel Dis 6 (2000) 157-164
25. Evgenikos N., Bartolo D.C., Hamer-Hodges D.W., and Ghosh S. Assessment of ileoanal pouch inflammation by interleukin 1beta and interleukin 8 concentrations in the gut lumen. Dis Colon Rectum 45 (2002) 249-255
26. Sutherland L.R., Martin F., Greer S., Robinson M., Greenberger N., Saibil F., et al. 5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis. Gastroenterology 92 (1987) 1894-1898
27. Haskell H., Andrews C.W., Reddy S.I., Dendrinos K., Farraye F.A., Stucchi A.F., et al. Pathologic features and clinical significance of "backwash" ileitis in ulcerative colitis. Am J Surg Pathol 29 (2005) 1472-1481
28. Hata K., Watanabe T., Shinozaki M., and Nagawa H. Patients with extraintestinal manifestations have a higher risk of developing pouchitis in ulcerative colitis: multivariate analysis. Scand J Gastroenterol 38 (2003) 1055-1058
29. Kuisma J., Jarvinen H., Kahri A., and Farkkila M. Factors associated with disease activity of pouchitis after surgery for ulcerative colitis. Scand J Gastroenterol 39 (2004) 544-548
30. Achkar J.P., Al-Haddad M., Lashner B., Remzi F.H., Brzezinski A., Shen B., et al. Differentiating risk factors for acute and chronic pouchitis. Clin Gastroenterol Hepatol 3 (2005) 60-66